Health
Possible ‘Breakthrough’ Coronavirus Treatment With Natural Protein Cuts Risk of Death and Serious Symptoms by 79% – Good News Network
British firm Synairgen has tested SNG001, an inhalant of the protein interferon beta, that’s shown to cut COVID-19 death and symptom rate by 79%.
An aerosol-based protein inhalant has been shown in trials to reduce the risk of death from SARS-CoV-2 and reduce the chance of developing serious symptoms by 79% compared to patients given a placebo.
Results also showed that patients were more than twice as likely to make a full recovery from Covid-19, meaning they had no lasting respiratory weakness or other damages.
The new drug called SNG001 is an inhalant of the naturally-occurring protein called interferon beta, and arose out of research…
Continue Reading